• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CDR3 和 V 基因在异基因骨髓移植后 T 细胞受体库中表现出不同的重建模式。

CDR3 and V genes show distinct reconstitution patterns in T cell repertoire post-allogeneic bone marrow transplantation.

机构信息

The Goodman Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel.

Department of Mathematics, Bar Ilan University, Ramat Gan, Israel.

出版信息

Immunogenetics. 2021 Apr;73(2):163-173. doi: 10.1007/s00251-020-01200-7. Epub 2021 Jan 21.

DOI:10.1007/s00251-020-01200-7
PMID:33475766
Abstract

Restoration of T cell repertoire diversity after allogeneic bone marrow transplantation (allo-BMT) is crucial for immune recovery. T cell diversity is produced by rearrangements of germline gene segments (V (D) and J) of the T cell receptor (TCR) α and β chains, and selection induced by binding of TCRs to MHC-peptide complexes. Multiple measures were proposed for this diversity. We here focus on the V-gene usage and the CDR3 sequences of the beta chain. We compared multiple T cell repertoires to follow T cell repertoire changes post-allo-BMT in HLA-matched related donor and recipient pairs. Our analyses of the differences between donor and recipient complementarity determining region 3 (CDR3) beta composition and V-gene profile show that the CDR3 sequence composition does not change during restoration, implying its dependence on the HLA typing. In contrast, V-gene usage followed a time-dependent pattern, initially following the donor profile and then shifting back to the recipients' profile. The final long-term repertoire was more similar to that of the recipient's original one than the donor's; some recipients converged within months, while others took multiple years. Based on the results of our analyses, we propose that donor-recipient V-gene distribution differences may serve as clinical biomarkers for monitoring immune recovery.

摘要

异基因骨髓移植(allo-BMT)后 T 细胞 repertoire 多样性的恢复对于免疫重建至关重要。T 细胞多样性是通过 T 细胞受体(TCR)α和β链的胚系基因片段(V(D)和 J)的重排以及 TCR 与 MHC-肽复合物结合所诱导的选择产生的。已经提出了多种措施来实现这种多样性。我们在这里重点关注β链的 V 基因使用和 CDR3 序列。我们比较了多个 T 细胞 repertoire,以跟踪 HLA 匹配的相关供体和受体对 allo-BMT 后 T 细胞 repertoire 的变化。我们对供体和受体互补决定区 3(CDR3)β组成和 V 基因谱之间差异的分析表明,CDR3 序列组成在恢复过程中不会发生变化,这意味着它依赖于 HLA 分型。相比之下,V 基因的使用遵循时间依赖性模式,最初遵循供体的模式,然后回落到受体的模式。最终的长期 repertoire 与受体的原始 repertoire 更相似,而不是供体的;一些受体在数月内收敛,而另一些则需要多年时间。基于我们分析的结果,我们提出供体-受体 V 基因分布差异可作为监测免疫重建的临床生物标志物。

相似文献

1
CDR3 and V genes show distinct reconstitution patterns in T cell repertoire post-allogeneic bone marrow transplantation.CDR3 和 V 基因在异基因骨髓移植后 T 细胞受体库中表现出不同的重建模式。
Immunogenetics. 2021 Apr;73(2):163-173. doi: 10.1007/s00251-020-01200-7. Epub 2021 Jan 21.
2
Distinct TCRAV and TCRBV repertoire and CDR3 sequence of T lymphocytes clonally expanded in blood and GVHD lesions after human allogeneic bone marrow transplantation.人类同种异体骨髓移植后,血液和移植物抗宿主病(GVHD)损伤中克隆性扩增的T淋巴细胞具有独特的T细胞受体α可变区(TCRAV)和T细胞受体β可变区(TCRBV)谱系及互补决定区3(CDR3)序列。
Bone Marrow Transplant. 2002 Dec;30(12):915-23. doi: 10.1038/sj.bmt.1703730.
3
T-Cell immune reconstitution in pediatric leukemia patients after allogeneic bone marrow transplantation with T-cell-depleted or unmanipulated grafts: evaluation of overall and antigen-specific T-cell repertoires.儿童白血病患者接受去除T细胞或未处理移植物的异基因骨髓移植后的T细胞免疫重建:总体及抗原特异性T细胞库评估
Blood. 1999 Dec 15;94(12):4358-69.
4
Donor T-Cell Repertoire Profiling in Recipient Lymphoid and Parenchyma Organs Reveals GVHD Pathogenesis at Clonal Levels After Bone Marrow Transplantation in Mice.供者 T 细胞受体谱在受者淋巴和实质器官中的分析揭示了骨髓移植后小鼠 GVHD 的克隆发病机制。
Front Immunol. 2021 Dec 7;12:778996. doi: 10.3389/fimmu.2021.778996. eCollection 2021.
5
Non-productive human TCR beta chain genes represent V-D-J diversity before selection upon function: insight into biased usage of TCRBD and TCRBJ genes and diversity of CDR3 region length.非功能性人类TCRβ链基因代表了功能选择前的V-D-J多样性:对TCRBD和TCRBJ基因的偏向性使用以及CDR3区域长度多样性的深入了解。
Hum Immunol. 1999 Nov;60(11):1090-100. doi: 10.1016/s0198-8859(99)00099-3.
6
[The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation].[异基因造血干细胞移植后白血病患者T细胞免疫重建的分子特征]
Zhonghua Xue Ye Xue Za Zhi. 2007 May;28(5):312-7.
7
T Cell Repertoire Evolution after Allogeneic Bone Marrow Transplantation: An Organizational Perspective.异基因骨髓移植后 T 细胞受体库的演变:组织学视角。
Biol Blood Marrow Transplant. 2019 May;25(5):868-882. doi: 10.1016/j.bbmt.2019.01.021. Epub 2019 Jan 21.
8
T cell receptor CDR3 loop length repertoire is determined primarily by features of the V(D)J recombination reaction.T细胞受体CDR3环长度谱主要由V(D)J重组反应的特征决定。
Eur J Immunol. 2003 Jun;33(6):1568-75. doi: 10.1002/eji.200323961.
9
Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism.T细胞去除的异基因骨髓移植后T细胞受体库多样性的重建与造血嵌合体有关。
Blood. 2000 Jan 1;95(1):352-9.
10
Long-term T cell immune reconstitution in 2 SCID patients after BMT.两名重症联合免疫缺陷(SCID)患者骨髓移植后T细胞的长期免疫重建
Hum Immunol. 1998 Apr;59(4):225-38. doi: 10.1016/s0198-8859(98)00013-5.

引用本文的文献

1
Naive and memory T cells TCR-HLA-binding prediction.初始和记忆性T细胞TCR-HLA结合预测。
Oxf Open Immunol. 2022 May 26;3(1):iqac001. doi: 10.1093/oxfimm/iqac001. eCollection 2022.
2
Counting is almost all you need.计数几乎是你所需要的全部。
Front Immunol. 2023 Jan 20;13:1031011. doi: 10.3389/fimmu.2022.1031011. eCollection 2022.
3
Autoencoder based local T cell repertoire density can be used to classify samples and T cell receptors.基于自动编码器的局部 T 细胞受体库密度可用于对样本和 T 细胞受体进行分类。

本文引用的文献

1
Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后 1 年的 T 细胞受体遗传多样性。
Leukemia. 2020 May;34(5):1422-1432. doi: 10.1038/s41375-019-0654-y. Epub 2019 Nov 26.
2
T Cell Repertoire Evolution after Allogeneic Bone Marrow Transplantation: An Organizational Perspective.异基因骨髓移植后 T 细胞受体库的演变:组织学视角。
Biol Blood Marrow Transplant. 2019 May;25(5):868-882. doi: 10.1016/j.bbmt.2019.01.021. Epub 2019 Jan 21.
3
IL-7 Is the Limiting Homeostatic Factor that Constrains Homeostatic Proliferation of CD8 T Cells after Allogeneic Stem Cell Transplantation and Graft-versus-Host Disease.
PLoS Comput Biol. 2021 Jul 26;17(7):e1009225. doi: 10.1371/journal.pcbi.1009225. eCollection 2021 Jul.
4
Clinical and basic implications of dynamic T cell receptor clonotyping in hematopoietic cell transplantation.动态 T 细胞受体克隆分型在造血细胞移植中的临床和基础意义。
JCI Insight. 2021 Jul 8;6(13):e149080. doi: 10.1172/jci.insight.149080.
白细胞介素 7 是同种异体干细胞移植和移植物抗宿主病后限制 CD8 T 细胞稳态增殖的限制因素。
Biol Blood Marrow Transplant. 2019 Apr;25(4):648-655. doi: 10.1016/j.bbmt.2018.12.066. Epub 2018 Dec 19.
4
Exploring the pre-immune landscape of antigen-specific T cells.探索抗原特异性 T 细胞的先天免疫景观。
Genome Med. 2018 Aug 25;10(1):68. doi: 10.1186/s13073-018-0577-7.
5
Predicting the spectrum of TCR repertoire sharing with a data-driven model of recombination.基于重组数据驱动模型预测 TCR 库共享谱。
Immunol Rev. 2018 Jul;284(1):167-179. doi: 10.1111/imr.12665.
6
Comparative analysis of murine T-cell receptor repertoires.鼠 T 细胞受体库的比较分析。
Immunology. 2018 Feb;153(2):133-144. doi: 10.1111/imm.12857. Epub 2017 Nov 27.
7
High-throughput sequencing of the T-cell receptor repertoire: pitfalls and opportunities.高通量测序 T 细胞受体库:陷阱与机遇。
Brief Bioinform. 2018 Jul 20;19(4):554-565. doi: 10.1093/bib/bbw138.
8
Strategies before, during, and after hematopoietic cell transplantation to improve T-cell immune reconstitution.造血细胞移植前、移植中和移植后改善 T 细胞免疫重建的策略。
Blood. 2016 Dec 8;128(23):2607-2615. doi: 10.1182/blood-2016-06-724005. Epub 2016 Oct 3.
9
Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide.移植后环磷酰胺治疗后T细胞库的起源与演变
JCI Insight. 2016;1(5). doi: 10.1172/jci.insight.86252. Epub 2016 Apr 21.
10
Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide.单倍体相合骨髓和干细胞移植:移植后环磷酰胺的应用经验
Semin Hematol. 2016 Apr;53(2):90-7. doi: 10.1053/j.seminhematol.2016.01.005. Epub 2016 Jan 15.